Skip to main content

Table 3 The result of cell survival rate (% reduction of AlamarBlue) of different primary cells derived from feline injection site sarcomas (FISSs) following treatment with different concentrations of 5-hydroxy-9,10-dioxo-9,10-dihydroanthracene-1-sulfonamide (LLL12) for 1-3 days

From: Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma

  FISS-10       FISS-14      
LLL12 day 1   day 2   day 3   day 1   day 2   day 3  
(μM) Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
2 31.892 0.186 23.754 0.242 32.665 0.177 11.279 0.585 17.964 0.399 14.257 0.482
1 37.898 0.594 23.494 0.151 32.586 0.160 15.272 0.580 16.165 0.297 14.692 0.244
0.5 39.305 1.025 25.812 0.562 34.366 0.192 41.122 2.812 69.744 3.587 57.243 3.394
0.25 60.345 1.347 49.953 0.939 56.049 0.736 46.300 14.753 79.969 16.165 88.842 3.645
0.125 71.976 1.316 67.882 2.125 90.040 1.662 62.514 10.629 139.298 1.913 109.572 3.076
DMSO 122.028 1.679 121.097 3.457 159.510 4.100 104.645 6.453 161.766 3.668 98.890 22.530
0 100.000 1.952 100.000 3.845 100.000 9.086 100.000 2.012 100.000 21.695 100.000 9.935